Makary Signals Some Interest In US FDA Staff Cuts, Fighting Patent Thickets

 
• By Sarah Karlin-Smith
  
Close up of FDA headquarters building with FDA sign.
FDA Commissioner nominee Martin Makary said he would assess agency personnel and would be "surgical" with any reductions. (Tada Images/Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from R&D